Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.

NCT02859350 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: PfSPZ Vaccine
BIOLOGICAL: PfSPZ Challenge (for CHMI)
OTHER: Normal Saline
BIOLOGICAL: PfSPZ Challenge (for PfSPZ-CVac)

Sponsor

Sanaria Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]